Heron Therapeutics, Inc. Profile Avatar - Palmy Investing

Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …

Biotechnology
US, San Diego [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of HRTX's Analysis
CIK: 818033 CUSIP: 427746102 ISIN: US4277461020 LEI: - UEI: -
Secondary Listings
HRTX has no secondary listings inside our databases.